• 5th Floor. Amrita Tower, KPCC Junction, MG Road Kochi
  • Ulcerative Colitis
    ★ The phase 2 Clinical Trial of PNB - 001 is completed ★
    ★ The clinical results are better than Pfizer's new drug Velsipity ★
    ★ Going for the final phase 3 clinical trials in India soon ★
  • Crohn's Disease
    ★ The phase 2 Clinical trial PNB - 001 is currently ongoing and will be completed before April 2024 ★
    ★ Results will come out on April 2024 ★
  • Colon Cancer & Pancreatic Cancer
    ★ The Tata Memorial Hospital has initiated the Phase 1/2 Colon cancer & Pancreatic cancer Clinical Trials of PNB-028 ★
    ★ The trial will be completed by March 2025 ★
  • Diabetes
    ★ The government of India has approved the phase 2 clinical trial of PNB-001 for Diabetes Mellitus ★
    ★ The drug is working based on a new Mechanism of Action ★
    ★ The phase 2 clinical trial will be completed by December 2024 and phase 3 before December 2025 ★
  • COVID-19
    ★ The Phase 3 clinical trial of PNB -001 was initiated in India after completing the Phase 2 clinical trials ★
    ★ The latest dominant COVID-19 variant is not damaging the patient's Lungs ★
    ★ The phase 3 clinical study is at a standstill now because our drug is for serious lung inflammatory conditions ★
  • Opioid & Drug Addiction Disorders
    ★ We have signed 3 contracts with the US Govt. (NIH / NIDA) to develop drugs for Opioid & Drug addiction disorders ★
    ★ The US government has declared Opioid & Drug addiction disorders as a national calamity ★
    ★ The studies in association with the US Govt. (NIH / NIDA) are currently ongoing. The initial test results are very promising ★

PNB Vesper, Focused on Developing Drugs for Unmet Medical Needs

PNB Vesper Life Sciences Pvt. Ltd is a research-based pharmaceutical organization that is determined to discover drugs for serious diseases and unmet medical conditions. PNB Vesper is currently one of very few companies in India focusing only on research-based NCEs, rather than generics. The company based in Kochi, India was incorporated in the year 2011. The company’s promoters have been contracting its NCE synthesis and related research and development activities, preclinical and clinical studies with various reputed academic and commercial organizations in the UK, US, Thailand, and India for the last 14 years (even before incorporating PNB Vesper Life Science in 2011).

Our Core Values

We believe that there are no limits to what we can accomplish as a Research company and are always willing to explore new ideas and forward-thinking in our Research. Our strength is the commitment of our team. We work together in support of one another to achieve the company’s goals and objectives. We support continuous efforts that lead to the discovery of new molecules for unmet diseases, improvements in the processes and products.

  • Passionate about our commitment to provide breakthrough therapy
  • Nurture a positive Global environment and setting a model for others to follow.
  • Breakthrough technology that will lead to better drugs and therapeutics.
  • Value our customers (patients) and stake holders with utmost respect.
  • Excellence in quality and in everything we do.
  • Seek new areas to innovate and grow.
  • Profitable and sustainable growth.
  • Ethics in every step of our way.
  • Respect our partners and associates..

100 +

Years of Research
Experience

Our Core Values

Our Research Molecules

PNB Vesper is focused to develop cost effective drugs for unmet medical needs. We have synthesized hundreds of molecules and systematically characterized to select the lead molecules. The lead molecules have the potential to treat variety of diseases including Covid 19, Inflammatory Pain, Different kinds of Cancer's, Inflammatory bowel disease (IBD), Neurological diseases such as Anxiety, Depression, Metabolic diseases and others.
PNB VESPER ON

Publications

PNB Vesper Life Sciences Pvt. Ltd is a research-based bio-pharmaceutical organization that is determined to discover drugs for serious diseases and unmet medical conditions. PNB Vesper is currently one of very few companies in India.

Recent News and Media Coverages

Our research is widely covered by various media's domestically and internationally through the print and electronic mediums.
The Future of Clinical Research in India: Opportunities and Growth Prospects

Clinical research in India is poised for an era of exponential growth, presenting a landscape rich with potential opportunities. As the global hub for pharmaceutical and biotech research, India stands at the cusp of transformative advancements in the clinical research … Continued

READ MORE
Global Impact: How Indian Biopharmaceutical Companies are Changing Medicine

The landscape of Biopharmaceutical companies in India stands as a testament to the transformative power of innovation in medicine by the nation. These entities have redefined the norms of drug discovery and development, showcasing their prowess on a global stage … Continued

READ MORE
The Role of Molecule Research in India’s Pharmaceutical Landscape

India has been a global centre for medicine in recent decades, and molecular research has played a critical role in this amazing success story. A key component of India’s pharmaceutical industry, molecules research is the process of finding and creating … Continued

READ MORE